Supreme Magnesium Powder 300g

Supreme Magnesium Soluble food supplement, a formula that, dissolved in water, is converted into magnesium citrate.
Dedicated production cycle without contamination of foreign substances. No GMOs. Citric acid from natural fermentation.
Magnesium
It is a fundamental nutrient, which helps produce essential energy for the body. It participates in the metabolism of sugars, proteins, fats and carbohydrates, in the acid-base balance, fights allergies, inflammation, is an excellent cardioprotector and stimulates the formation of antibodies.
Its action acts directly on the body, promoting a correct and efficient activity of enzymes, which we know are the catalysts of certain fundamental chemical reactions in the body.
One of the most important tasks that magnesium has is to regulate the levels of calcium taken and to promote its correct absorption. Calcium and magnesium work synergistically to control muscle action; when the right amount of magnesium is not entered in the body, the muscles remain contracted giving rise to cramps.
Magnesium is a totally safe mineral, in fact, by taking in excess, the body will retain the necessary quantity, eliminating the rest.
The intake of powdered magnesium, diluted in hot water, is the ideal formula, due to its bioavailability suitable for everyone, from children to the elderly.

How to use
- Powder: one teaspoon (about 2.4 g) in hot water. One or two teaspoons of powder per day is recommended.
- Sachets: we recommend taking 2 sachets a day to be diluted in hot water.
Wait for the drink to become clear before drinking.

Warnings
For pregnant or lactating women and children it is recommended to seek medical advice.
Do not exceed the recommended daily dose.
Keep out of the reach of children under three years of age.
Supplements are not intended as a substitute for a varied diet.

Format
Jar of 150 g.
300 g jar.
32 disposable sachets.

Bibliography
- Hentrotte JG. Type A behavior and magnesium metabolism. Magnesium 1986; 5: 201-210.
- Frustaci A, Caldarulo M, Schaivoni G, Belloci F, Manzoli U, et al. Myocardial magnesium content, histology, and antiarrhythmic response to magnesium. Lancet 1987; 2: 1019.
- Rusmussen HS, Norregard P, Lindeneg O, MacNair P, Backer V, et al. Intravenous magnesium in acute myocardial infarction. Lancet 1986; 1: 234-236.
- Shwechter M, Hod H, Marks N, Behar S, Kaplinsky E, et al. Benefi cial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol 1990; 66: 271-274.
- Seller RH. The role of magnesium in digitalis toxicity. Am Heart J 1971; 2: 551-556.
- England MR, Gordon G, Salem M, Chernow B. Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial. JAMA 1992; 268: 2395-2402.
- Wener J., Pintar K, Simon MA, Motola R. Friedman R, et al. The effects of prolonged hypomagnesemia on the cardiovascular system in young dogs. Am Heart J 1964; 67: 221- 231.
- Motoyama T, Sano H, Fukuzaki H. Oral magnesium supplementation in patients with essential hypertension. Hypertension 1989; 13: 227-232.
- Dyckner T, Wester PO. Effect of magnesium on blood pressure. Br Med J 1983; 286: 1847- 1849.
- Henderson DG, Schierup J, Schodt T. Effect of magnesium supplementation on blood pressure and electrolyte concentrations in hypertensive patients receiving long-term diuretic treatmet. Br Med J 1986; 293: 664.
- FP Hood, Markandu ND, Beynon GW, Shore AC, Sampson B, et al. Lack of effect of oral magnesium on high blood pressure: a double-blind study. Br Med J 1985; 291: 235- 238.
- Alyura BT, Altura BM. The role of magnesium in etiology of strokes and cerebrovasospasm. Magnesium 1982; 1: 277-291.
- Galland LD, Baker SM, McLellan RK. Magnesium defi ciency in the pathogenesis of mitral valve prolapse. Magnesium 1986; 5: 165-174.
- Fernandes JS, Perira T, Carvalho J., Franca A, Andrade R, et al. Therapeutic effect of magnesium salt in patients suffering from mitral valvular prolapse and latent tetany. Magnesium 1985; 4: 283-290.
- Cox IM, Campbell MJ, Dowson D. Red blood cell magnesium and chronic fatigue syndrome. Lancet 1991; 337: 757-760.
- Clague JE, Edwards RHT, Jackson MJ. Intravenous magnesium loading in chronic fatigue syndrome. Lancet 1992; 340: 124-125.
- Deulofeu R, Garson J, Gimenez N, Corachan M. Magnesium and chronic fatigue syndrome. Lancet 1991; 338: 641.
- Shines LR, Haley TF. Effect of magnesium supplementation on strength training in humans. J Am Coll Nutr 1992; 11: 326-329.
- Shines LR, Wenos DL. Perceived exertion to endurance exercise following magnesium supplementation. Magnesium Trace Elem 1990; 9: 319-320.